SCHOTT Creates Stand-alone Company for Pharma Business


Division will operate under SCHOTT Pharma AG & Co. KGaA

SCHOTT, a provider of pharma drug containment and system solutions, has legally established a stand-alone company for its pharma business to advance its growth strategy. Per the move, the pharma business will now operate under the new name SCHOTT Pharma AG & Co. KGaA.

“By creating a separate legal entity for our pharma business, we are generating new opportunities to expedite our profitable growth,” says Frank Heinricht, PhD, SCHOTT CEO. “Pharma will remain an integral part of SCHOTT in the future. With this move, we are creating more room for organic and inorganic growth and further potential investments towards becoming climate neutral by 2030.”

Pharma drug containment and system solutions, just as drug manufacturing, is subject to various regulations. SCHOTT’s portfolio ranges from high-quality vials to glass and polymer syringes, to cartridges and ampoules—the company manufactures products to serve modern drug categories, such as mRNA-based drugs and biopharmaceuticals.



Source link